NCT02931981

Brief Summary

Our study aims to evaluate the role of Dickkopf-4 as biomarkers in the treatment of gastrointestinal stromal tumor.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

October 11, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 13, 2016

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
Last Updated

October 13, 2016

Status Verified

October 1, 2016

Enrollment Period

Same day

First QC Date

October 11, 2016

Last Update Submit

October 11, 2016

Conditions

Gastrointestinal Stromal Tumor

Keywords

DKK4Gastrointestinal Stromal TumorBiomarker

Outcome Measures

Primary Outcomes (1)

  • Overall Survival

    3 years

Secondary Outcomes (1)

  • Relapse-free Survival

    3 years

Interventions

surgery or biopsyPROCEDURE

Do radical surgery or biopsy to obtain a pathological result

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with gastrointestinal stromal tumor.

You may qualify if:

  • Primary gastrointestinal stromal tumor confirmed pathologically by surgery or biopsy
  • Age from 18 - 70 years
  • No serious organic and mental illness;

You may not qualify if:

  • Pregnancy
  • No pathologic result
  • Suffering other malignancies at the same time.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ethics Committee of Renji Hospital, School of Medicine,Shanghai Jiaotong University

Shanghai, 200127, China

RECRUITING

MeSH Terms

Conditions

Gastrointestinal Stromal Tumors

Interventions

Surgical Procedures, OperativeBiopsy

Condition Hierarchy (Ancestors)

Neoplasms, Connective TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsDigestive System DiseasesGastrointestinal Diseases

Intervention Hierarchy (Ancestors)

CytodiagnosisCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisSpecimen HandlingDiagnostic Techniques, SurgicalInvestigative Techniques

Central Study Contacts

Hui Cao, PhD

CONTACT

008602168383751caohuishcn@hotmail.com

Lin Tu, MD

CONTACT

008618616547270tl19870228@hotmail.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 11, 2016

First Posted

October 13, 2016

Study Start

October 1, 2016

Primary Completion

October 1, 2016

Study Completion

October 1, 2019

Last Updated

October 13, 2016

Record last verified: 2016-10

Locations

CN(1)